The Social Media Press Release ties together various multimedia
elements in one location which allows a journalist or blogger to view and/or
re-mix the media elements for their own stories.
Impact Medical Solutions Updates
Pilot Clinical Trial of Muscle Pattern Recognition (MPR) System
Muscle Pattern Recognition (MPR) technology will be the first quantitative tool
developed for assisting in the diagnosis of the presence or absence of a
musculoskeletal dysfunction (sprain/strain injuries) and will substantially
improve the accuracy of diagnosis, rehabilitation and case management decisions.
·
(Huntington Beach, CA - April 23, 2009) -
Impact Medical Solutions, Inc. (OTCBB:
IMSU, FWB: 0IM),
an information technology company, today updated the status of
its pilot clinical trial of the Company’s proprietary
information technology platform,
Muscle Pattern Recognition (MPR).
·
MPR is a unique clinical tool that analyzes patterns of muscle recruitment.
It provides detailed physiological information on muscle function that can
assist in the diagnosis and treatment of back and neck injuries and illness.
·
The Company announced that it had recruited its 150th trial subject
since the trial was first announced on February 25, 2009 and that patient
recruitment continues to be strong.
·
The pilot clinical trial is currently being conducted at the Utah Spine and
Joint Center in Salt Lake City, Utah and the total trial is expected to involve
several hundred subjects, many of whom are experiencing chronic back pain.
·
Additional clinical trials are scheduled for California (late 2nd
Quarter 2009) and Michigan in the summer of 2009.
·
Clinical Trial data will be submitted to FDA in 4th Quarter 2009.
·
Muscle Pattern Recognition (MPR) is a patented and proprietary technology.
QUOTES – ATTRIBUTABLE TO:
ALAN GOLDMAN, M.D. Vice President Clinical and Medical Affairs
“The MPR technology will be the first quantitative tool developed for assisting
in the diagnosis of the presence or absence of a musculoskeletal dysfunction
(sprain/strain injuries) in a patient population.”
“The availability of such an evaluation tool to a healthcare provider for
patients with soft tissue, non-surgical neck or back complaints will
substantially improve the accuracy of diagnosis, rehabilitation and case
management decisions.”
WAYNE COCKBURN, President & CEO of Impact Medical Solutions
“We are ahead of schedule as far as testing is concerned and we’re pleased to
report that the MPR System is performing at or above our expectations, and our
expectations are high.”
“There is currently a two to three week waiting list to get into our trial and
we anticipate this trend to continue. We are planning on opening a
second
test site in Southern California within the next several weeks and a third
site in Michigan during the summer. We expect the results of this pilot
trial will be used in our submission to FDA later this year.”
.....................................Please
contact Dianemarie (DM) Collins to arrange an
interview and/or for additional quotes.
EMBED THIS VIDEO INTO YOUR BLOG OR NEWSITE
DM Productions produced
this video for iTech Medical
on the new breakthrough medical diagnostic tool MPR - Muscle Pattern
Recognition which will help treat people with chronic back pain and neck
pain. iTech Medical is currently in the clinical trials on MPR and
will apply later this year to the FDA.
Mr. Cockburn
joined Impact Medical in September 2003 and is the founder. Prior to
Impact Medical, Mr. Cockburn was President at MPR Health Systems from January
2002 until September 2003 and Executive Vice President from January 2000 until
January 2002. From January 1995 to December 1999, Mr. Cockburn was Vice
President, Business Development for Lorus Therapeutics, a public biotechnology
company. Mr. Cockburn’s background includes strategic planning, corporate
finance, corporate partnering, corporate governance and mergers and
acquisitions. Mr. Cockburn has served on the board of directors of several
private and public companies. Mr. Cockburn currently serves on the board of
directors of MPR Health Systems, Inc., Red Juggernaut, Inc. and Litewave
Corporation.
Dr. Goldman
joined Impact Medical in September 2003. Prior to joining Impact Medical, Dr.
Goldman was a practicing Board Certified neurologist for 27 years and an
Associate Clinical Professor of Neurology at the University of California
(Irvine). Through his practice, Dr. Goldman attained extensive experience with
work-related injuries. He served as a neurology consultant to numerous insurers
and served for four years on the Medical Advisory Board of Blue Cross. Dr.
Goldman serves as an expert witness in Workers’ Compensation and general
liability litigation matters and was recently appointed as a Medical Panel
Chairperson for the State of Utah Labor Commission. His Workers’ Compensation
appointments include Independent Medical Examiner for the State of California in
1990, Qualified Medical Evaluator, State of California in 1991 and Agreed
Medical Evaluator, State of California in 1992. Dr. Goldman is also a member of
the American Academy of Neurology, the California Medical Association, the Utah
Medical Association and a Past-President of the Orange County Neurological
Society.
At Impact
Medical Solutions, Dr. Goldman is responsible for all the clinical and medical
affairs of the Company. In addition to being a key member of the management
team, Dr. Goldman also serves as Chairman of the Company's Medical Advisory
Board.
Steeve
Asselin - Vice President, Research and Development
Prior to joining
Impact Medical in September 2003, Mr. Asselin was the Director of the
Biomechanics Lab at HealthSouth Inc. from September 2000 to December 2002. Mr.
Asselin was responsible for the development of the Biomechanics Lab at
HealthSouth to enhance and support the clinical programs and services of the
company. From May 1994 until September 1999, Mr. Asselin was Research
Coordinator at Spinex Medical Technologies. From February 1992 until March 1994,
Mr. Asselin was Director, Clinical and Spinoscopy Affairs with a physician group
in Boston, Mass. Prior to that, Mr. Asselin was a Research Assistant at Spinex
Medical Technologies from September 1989 until February 1992. Mr. Asselin is
coauthor of six scientific publications dealing with back injuries and back
function and author and/or coauthor of approximately 30 scientific abstracts.
FORWARD LOOKING STATEMENTS
This news release contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 as contained in Section 27A of
the Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934 that reflect management's current views and estimates regarding future
market conditions, company performance and financial results, business
prospects, new strategies, the competitive environment and other events. You can
identify these statements by the fact that they use words such as "anticipate,"
"believe," "estimate," "expect," "intend," "project," "plan," "outlook," and
other words and terms of similar meaning. These statements involve a number of
risks and uncertainties that could cause actual results to materially differ
from the potential results discussed in the forward-looking statements. Among
the factors that could cause actual results and outcomes to differ materially
from those contained in such forward-looking statements are the following:
general economic conditions, acquisitions and development of new businesses,
divestitures, product availability, sales volumes, pricing actions and
promotional activities of our competitors, profit margins, weather, changes in
law or regulations, foreign currency fluctuation, availability of suitable real
estate locations, our ability to react to a disaster recovery situation, and the
impact of labor markets and new product introductions on our overall
profitability. A further list and description of these risks, uncertainties and
other matters can be found in the company's annual report and other reports
filed from time to time with the Securities and Exchange Commission, including,
but not limited to, Impact Medical Solutions, Inc's Annual Report on Form 10-K
filed with the SEC on April 17, 2007. Impact Medical Solutions cautions that the
foregoing list of important factors is not complete and assumes no obligation to
update any forward-looking statements that it may make.
